$2.77 Billion is the total value of Rubric Capital Management LP's 72 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GLNG | GOLAR LNG LTD | $168,509,000 | +100.0% | 6,800,187 | 0.0% | 6.09% | +53.1% | |
| BGCP | BGC PARTNERS INCcl a | $68,200,000 | -5.4% | 15,500,000 | 0.0% | 2.47% | -27.6% | |
| RDUS | RADIUS HEALTH INC | $61,451,000 | +27.6% | 6,959,305 | 0.0% | 2.22% | -2.4% | |
| TAC | TRANSALTA CORP | $53,759,000 | -6.8% | 5,189,062 | 0.0% | 1.94% | -28.7% | |
| PARR | PAR PAC HOLDINGS INC | $48,174,000 | -21.0% | 3,700,000 | 0.0% | 1.74% | -39.6% | |
| CMRX | CHIMERIX INC | $21,984,000 | -28.8% | 4,800,000 | 0.0% | 0.80% | -45.5% | |
| ADV | ADVANTAGE SOLUTIONS INC | $12,055,000 | -20.5% | 1,889,574 | 0.0% | 0.44% | -39.1% | |
| MAX | MEDIAALPHA INCcl a | $10,502,000 | +7.2% | 634,579 | 0.0% | 0.38% | -17.9% | |
| KDNY | CHINOOK THERAPEUTICS INC | $9,233,000 | +0.3% | 564,353 | 0.0% | 0.33% | -23.2% | |
| CTMX | CYTOMX THERAPEUTICS INC | $6,425,000 | -38.3% | 2,406,449 | 0.0% | 0.23% | -52.8% | |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | $3,245,000 | -16.2% | 747,607 | 0.0% | 0.12% | -36.1% | |
| QSI | QUANTUM SI INC | $3,147,000 | -40.5% | 672,385 | 0.0% | 0.11% | -54.4% | |
| TXMD | THERAPEUTICSMD INC | $2,031,000 | +6.9% | 5,344,302 | 0.0% | 0.07% | -18.9% | |
| SIOX | SIO GENE THERAPIES INC | $2,010,000 | -48.1% | 3,000,000 | 0.0% | 0.07% | -60.1% | |
| VIAO | VIA OPTRONICS AGsponsored ads | $2,015,000 | +8.9% | 251,855 | 0.0% | 0.07% | -16.1% | |
| REPH | SOCIETAL CDMO INC | $1,938,000 | +5.3% | 1,076,587 | 0.0% | 0.07% | -19.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAGNACHIP SEMICONDUCTOR CORP | 28 | Q3 2023 | 4.7% |
| BGC PARTNERS INC | 20 | Q2 2023 | 4.6% |
| MR COOPER GROUP INC | 20 | Q3 2023 | 5.9% |
| PAR PACIFIC HOLDINGS INC | 18 | Q3 2023 | 3.9% |
| RADIUS HEALTH INC | 16 | Q2 2022 | 4.3% |
| CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q3 2023 | 2.6% |
| HERON THERAPEUTICS INC | 15 | Q3 2023 | 9.0% |
| COLLEGIUM PHARMACEUTICAL INC | 15 | Q3 2023 | 3.9% |
| AAR CORP | 14 | Q3 2023 | 3.2% |
| GREEN PLAINS INC | 14 | Q3 2022 | 4.1% |
View Rubric Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ | July 25, 2023 | 26,713,503 | 19.0% |
| Amryt Pharma plc | February 10, 2023 | 18,000,000 | 5.6% |
| BGC Partners, Inc. | February 10, 2023 | 18,250,000 | 5.6% |
| EverQuote, Inc. | February 10, 2023 | 1,246,622 | 4.8% |
| Ferroglobe PLC | February 10, 2023 | 3,232,762 | 1.7% |
| Sio Gene Therapies Inc. | February 10, 2023 | 7,000,000 | 9.5% |
| Vincerx Pharma, Inc. | February 10, 2023 | 386,719 | 1.8% |
| Whole Earth Brands, Inc. | February 10, 2023 | 998,363 | 2.4% |
| Radius Health, Inc. | June 16, 2022 | 6,959,305 | 14.6% |
| ANTARES PHARMA, INC. | February 14, 2022 | 10,800,000 | 6.4% |
View Rubric Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| DFAN14A | 2024-05-08 |
| DFAN14A | 2024-05-03 |
| DFAN14A | 2024-05-01 |
| DFAN14A | 2024-04-30 |
| DFAN14A | 2024-04-29 |
| DEFC14A | 2024-04-17 |
| DFAN14A | 2024-04-17 |
| SC 13D/A | 2024-04-16 |
| PRRN14A | 2024-04-02 |
| PRRN14A | 2024-03-26 |
View Rubric Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.